NIH-funded research U01 cooperative agreement

Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it

Official title: Characterizing the evolution of impaired hypoglycemia awareness in people with type 1 diabetes and the impact of automated insulin delivery and exercise on restoring hypoglycemia awareness

Funded at University of Melbourne · NIH-11582458 · Data updated 2026-11-12

This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Melbourne
NIH-funded
Lab location1 site (Melbourne, Australia)
Project startSeptember 25, 2022
Project endDecember 31, 2027
Funding year2026
Award (this year)$377,631
NIH project number3U01DK135122-04S1
Project IDNIH-11582458 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 1 diabetes who have impaired hypoglycemia awareness and are willing to use automated insulin delivery and engage in exercise interventions.

Less likely to help

People without type 1 diabetes or those not experiencing impaired hypoglycemia awareness are unlikely to benefit from this specific study.

What this research studies

People with type 1 diabetes often lose the ability to recognize when their blood sugar is falling, which increases the risk of dangerous lows. The project will follow adults over several years to understand how this awareness changes and to test if new insulin-pump technology and regular high-intensity interval exercise can improve their ability to notice low blood sugar. Participants may use automated insulin delivery systems and participate in supervised exercise sessions as part of the trial. The findings could guide personalized treatment strategies to prevent severe hypoglycemia and improve safety. This work builds on prior observations that education and technology alone have not fully restored awareness in many individuals.

Why it matters

Potential benefit: If successful, the study could lead to better ways to prevent dangerous hypoglycemia by restoring warning signs and improving safety for people with type 1 diabetes.

How similar studies have gone: Previous small studies with education and CGM/AID technologies have shown limited, but promising, improvements in awareness over short periods.

Where this research is happening

  • University of Melbourne
    Melbourne, Australia
    Active

Researchers

  • Principal investigator: O'neal, David Norman — University of Melbourne
  • Study coordinator: O'neal, David Norman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.